Ian Pyrah
Impact in
-
- Bone health and osteoporosis research
- Bone and Joint Diseases
- Oncology top 10%
- Bone health and treatments
Papers in
-
- Bone Metabolism and Diseases 8
- Oncology 11
- Bone health and treatments 5
- Cytokine Signaling Pathways and Interactions 3
- Co-authors
- Michael S. Ominsky (10 shared papers)Rogely Boyce (11 shared papers)Susan Y. Smith (4 shared papers)Jacquelin Jolette (3 shared papers)Paul J. Kostenuik (2 shared papers)Joseph A. Schroeder (2 shared papers)Efrain Pacheco (4 shared papers)Scott L. Taylor (4 shared papers)
- Journals
- Toxicologic Pathology (9 papers)Bone (5 papers)Journal of Bone and Mineral Research (2 papers)Regulatory Toxicology and Pharmacology (2 papers)Reproductive Toxicology (2 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Ian Pyrah
31 papers receiving 813 citations
Peers
Comparison fields: 5 of 89
- Orthopedics and Sports Medicine 356
- Oncology 366
- Molecular Biology 465
- Nephrology 36
- Health, Toxicology and Mutagenesis 65
Countries citing papers authored by Ian Pyrah
This map shows the geographic impact of Ian Pyrah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Pyrah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Pyrah more than expected).
Fields of papers citing papers by Ian Pyrah
This network shows the impact of papers produced by Ian Pyrah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Pyrah. The network helps show where Ian Pyrah may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian Pyrah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 77 | |
| 2 | 2011 | 73 | |
| 3 | 2015 | 72 | |
| 4 | 2016 | 72 | |
| 5 | 2011 | 72 | |
| 6 | 2016 | 59 | |
| 7 | 2015 | 55 | |
| 8 | 2014 | 39 | |
| 9 | 1999 | 38 | |
| 10 | 2008 | 36 | |
| 11 | 2001 | 31 | |
| 12 | 1999 | 30 | |
| 13 | 2013 | 29 | |
| 14 | 1999 | 26 | |
| 15 | 2018 | 24 | |
| 16 | 2007 | 21 | |
| 17 | 2018 | 17 | |
| 18 | 1996 | 13 | |
| 19 | 2009 | 10 | |
| 20 | 1995 | 9 |
About Ian Pyrah
Ian Pyrah is a scholar working on Molecular Biology, Oncology, Immunology, Orthopedics and Sports Medicine and Small Animals, having authored 32 papers that have together received 847 indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (8 papers), Bone health and osteoporosis research (7 papers), Animal testing and alternatives (6 papers), Immunotoxicology and immune responses (5 papers), Bone health and treatments (5 papers), Cytokine Signaling Pathways and Interactions (3 papers), Erythropoietin and Anemia Treatment (3 papers) and Estrogen and related hormone effects (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (356 citations), Oncology (366 citations), Molecular Biology (465 citations), Nephrology (36 citations) and Health, Toxicology and Mutagenesis (65 citations). Ian Pyrah has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Michael S. Ominsky, Rogely Boyce, Susan Y. Smith, Jacquelin Jolette, Paul J. Kostenuik, Joseph A. Schroeder, Efrain Pacheco, Scott L. Taylor, Kathrin Locher and Marina Stolina. Their work appears in journals such as Toxicologic Pathology, Bone, Journal of Bone and Mineral Research, Regulatory Toxicology and Pharmacology and Reproductive Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.